Computational vaccine design, also known as computational vaccinology, encompasses epitope mapping, antigen selection and immunogen design using computational tools. The iVAX toolkit is an integrated set of tools that has been in development since 1998 by De Groot and Martin. It comprises a suite of immunoinformatics algorithms for triaging candidate antigens, selecting immunogenic and conserved T cell epitopes, eliminating regulatory T cell epitopes, and optimizing antigens for immunogenicity and protection against disease. iVAX has been applied to vaccine development programs for emerging infectious diseases, cancer antigens and biodefense targets. Several iVAX vaccine design projects have had success in pre-clinical studies in animal models and are progressing toward clinical studies. The toolkit now incorporates a range of immunoinformatics tools for infectious disease and cancer immunotherapy vaccine design. This article will provide a guide to the iVAX approach to computational vaccinology.
- Dogs on Bicycles and Hamster (Proteins) in Biologics!
- Amsterdam Immunogenicity & Tolerance Seminar November 18, 2022 **Updated with Pictures!**
- EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine
- Tregs In SARS-COV-2? Yes, There Are. And: Boston, Basel And Amsterdam Oh My!
- AAPS PharmSci 360, October 16-19, 2022 **Updated with Pictures!**